Trial · NCT07896720
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 19 of 19
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Surgical Success Rate | Perioperative | The proportion of participants who complete the planned surgical procedure without conversion to open surgery or other major intraoperative deviations. |
| Primary | Incidence of Grade 3 or Higher Complications | Up to 30 days after surgery | The proportion of participants who experience grade 3 or higher postoperative complications, as defined by the Clavien-Dindo classification. |
| Secondary | Overall Complication Rate | Up to 30 days after surgery | The proportion of participants who experience any postoperative complication, regardless of severity, including both surgical and medical complications. |
| Secondary | Operative Time (min) | Perioperative | The total duration of the surgical procedure, measured in minutes from skin incision to skin closure. |
| Secondary | Estimated Intraoperative Blood Loss (mL) | Perioperative | The estimated volume of blood lost during the surgical procedure, measured in milliliters. |
| Secondary | Positive Margin Rate (%) | Up to 30 days after surgery | The proportion of participants with positive surgical margins confirmed by postoperative pathological examination. |
| Secondary | Visual Analogue Scale (VAS) Pain Score | Postoperative Day 1 | The intensity of postoperative pain assessed using the Visual Analogue Scale (VAS). The scale ranges from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain". Higher scores indicate a worse outcome. |
| Secondary | Surgeon Satisfaction Score | Perioperative | The level of satisfaction reported by the operating surgeon regarding the surgical system and procedure, assessed using a 5-point Likert scale ranging from 1 (very dissatisfied) to 5 (very satisfied). Higher scores indicate a better outcome. |
| Secondary | Length of Hospital Stay (days) | Perioperative | The total number of days from admission to discharge after the surgical procedure. |
| Secondary | Transfusion Rate (%) | Perioperative | The proportion of participants who require blood transfusion during or after the surgical procedure. |
| Secondary | Readmission Rate (%) | Up to 30 days after discharge | The proportion of participants who are readmitted to the hospital for any cause after initial discharge. |
| Secondary | Reoperation Rate (%) | Up to 30 days after surgery | The proportion of participants who require a second surgical procedure related to the initial operation. |
| Secondary | Mortality Rate (%) | Through study completion, an average of 2 years | The proportion of participants who die from any cause during the study period. |
| Secondary | Device Defect Rate | Perioperative | The proportion of participants who experience any malfunction, defect, or failure of the MP2000 surgical system during the procedure. |
| Secondary | Adverse Event Rate | Through study completion, an average of 2 years | The proportion of participants who experience any adverse event during the study period. |
| Secondary | Serious Adverse Event Rate | Up to 1 year | The proportion of participants who experience any serious adverse event during the study period. |
| Secondary | Remote Operation Evaluation | Perioperative | Assessment of the performance and reliability of the remote operation, including signal latency, operational stability, and surgeon feedback, using a standardized evaluation form. |
| Secondary | Overall Survival (OS) | Up to 5 years | The time from randomization to death from any cause. |
| Secondary | Disease-Free Survival (DFS) | Up to 5 years | The time from randomization to the first occurrence of disease recurrence or death from any cause, whichever comes first. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07896720/registered